Your browser doesn't support javascript.
loading
Serum soluble DR5 predicts mortality risk in patients with HBV-related hepatocellular carcinoma.
Liang, Jiaqi; Feng, Ying; Liu, Yao; Shi, Ke; Zhou, Guiqin; Liu, Long; Liu, Yaxin; Qiao, Kexin; Liu, Wen; Wang, Xianbo.
Afiliación
  • Liang J; Department of Infectious Disease, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing,  China.
  • Feng Y; Department of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing,  China.
  • Liu Y; Department of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing,  China.
  • Shi K; Department of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing,  China.
  • Zhou G; Department of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing,  China.
  • Liu L; Department of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing,  China.
  • Liu Y; Department of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing,  China.
  • Qiao K; Department of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing,  China.
  • Liu W; Department of Infectious Disease, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing,  China.
  • Wang X; Department of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing,  China.
Front Oncol ; 12: 1040812, 2022.
Article en En | MEDLINE | ID: mdl-36605430
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article Pais de publicación: Suiza